A clinical and murine study in 2024 reported the elevation of immunosuppressive markers PD-L1 and IL-10 in immune cells (e.g., macrophages and dendritic cells) and tumor tissues from patients with advanced GC, compared to healthy individuals [66]. This evidence concerns the gene CD274 and neoplasm.